DFE Pharma is a global leader in pharma- and nutraceutical excipient solutions. We develop, produce and supply high-quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients are used in numerous medicinal and nutraceutical products, including COVID-19 vaccines and treatments.
In our more than a century of heritage, we always work for customer satisfaction from formulation development support to excipient supply. We provide our customers with our comprehensive technical expertise and support to efficiently navigate any regulatory space.
DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives, driven by our purpose your medicines, our solutions. Moving to a healthier world.
A leading portfolio of premium quality excipients
We differentiate ourselves as a excipients supplier of choice through our track record and well-known reputation for quality and consistency. We offer a wide range of over 200 premium products that play an essential role as fillers, binders, disintegrants, carriers and stabilizers.
In the Biopharma field, our BioHale® portfolio is comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, and can be used in various administration forms, such as for parenteral, inhalation, oral or ophthalmic route.
For Oral Solid Dose (OSD) formulations, we provide over 40 grades of milled-, sieved- and modified lactose, besides microcrystalline cellulose (MCC), superdisintegrants, starches and co-processed excipient solutions. We also develop customized blended forms.
As pioneers in the inhalation area, we produce a comprehensive range of lactose-based excipients, designed to offer the right characteristics for all inhaled medicines on the market. Furthermore, we can customize the lactose to meet the specific needs of our customers.
We also offer a comprehensive range of ingredients for nutraceutical products, comprising lactose including milled-, sieved-, anhydrous-, spray dried- and granulated lactose-, MCC, superdisintegrants, starches and multifunctional co-processed excipients.
Security of supply and technical support
We understand medicines and nutraceutical products are essential to patients and consumers and share our customers’ goal to deliver them in full and on time. To achieve this, we offer a Dual Sourcing system, meaning our products are produced at two different locations globally. So we can always be relied on the delivery of our products from one of our sites.
More than just a supplier, we are a partner in every phase of the product development and delivery. In this partnership we are constantly developing new services to support our pharmaceutical and nutraceutical companies with technical expertise, as well as with supply-, time to market- and risk mitigation services, striving always towards 100% reliability in our supply and premium quality.
Continuous innovation
Together with customers, suppliers and partners, we work towards the development of innovative products and transformative production methods, including 3D printing, Continuous Manufacturing and Biopharma solutions.
In May 2022, we open a new Closer to Formulator (C2F) Center of Excellence in India. This center supports the formulation or re-formulation of products, working with R&D teams of pharmaceutical companies globally. C2F enhances industry capabilities in excipient selection and formulation design, in line with the FDA’s ‘Quality-by-Design’ (QbD) mindset of integrating expertise and therefore quality into a product from the very start.
Our experts regularly publish scientific articles in our field, to advance innovation and spread knowledge. his supports other researchers in our field to become aware of new data, while it helps to advance knowledge and its applications across the industry.
Sustainable excipients
Our holistic view on sustainability encompasses balancing three main pillars Environmental, Social, and Governance (ESG). Our approach to ESG is driven by our purpose statement of “moving to a healthier world”. It’s our key priority to make our work more sustainable and future-proof by working with cleaner energy, being compliant with global regulations, and promoting equality among our workforces. As DFE Pharma, we recognize that we are part of a long value chain. Therefore, we recognize the benefits of collaborations throughout the entire value chain to accelerate our sustainability journey.
Global footprint
DFE Pharma is headquartered in Goch, Germany, and has around 450 DFE Pharma’s employees working worldwide. Currently, we operate 5 production locations (in the Netherlands, Germany, India and New Zealand) with access to a broader manufacturing network, and 7 sales offices to be close to customers, providing products and services to more than 5,000 customers in over 100 countries worldwide.
Products
Pharmacel® Microcrystalline Cellulose
SuperStarch® 200 Pregelatinized Starch
Pharmatose® Lactose monohydrate
Lactochem® Lactose monohydrate
SuperTab® Lactose
Lactopress® Spray Dried Lactose
Primellose® Croscarmellose sodium
Primojel® Sodium starch glycolate
Lactohale® Inhlation Grade Lactose
